Roth Capital reiterates its Buy rating and $40 price target on JinkoSolar Holding (NYSE: JKS) following Q4 results and outlook.Analyst ...
Credit Suisse analysts raised the 2015 EPS from $4.01 to $4.13 and 2016 EPS from $5.81 to $6.18 to reflect higher-than-expected shipments this year, and moderately higher operating expenditure next. The company also introduced 2017 EPS estimate of $5.94.
Analysts have given the stock an Outperform rating with a price target of $45, which was reiterated following yesterday’s quarterly results. Morgan Stanley (NYSE:MS) analyst Boris Kan also reiterated his Neutral rating on the stock and maintained a price target of $31.
Meanwhile, Goldman Sachs Group Inc's (NYSE:GS) equity research analyst, Frank Lee, maintained a Neutral rating on the stock but revised down the price target by $1 to $25. The same was done by Jefferies analyst Joseph Fong, who maintained a Buy rating on the stock but lowered the price target from $37.70 to $35.30.
Overall, the stock receives coverage from nine analysts across the Street, and has an average price target of $35.10. Six analysts suggest a Buy, while only one recommends a Sell. Following the strong quarterly results, JinkoSolar’s stock price last closed up 4.2% at $22.81.
they did everything they said they would. Guidance was great, year over year a big increase. The only negative that Gordon Johnson will jump all over is hooking up to the grid.
I'm not sure hat your talking about, partnership. On large projects I thought they used percentage complete so revenue can be recognized on several Qtrs
correction...Q3 earnings were in line at.71 when subtracting a $25m tax benefit. And revenue from down stream will NOT be recognized as revenue.
the more downstream they have, the less revenue and less earnings. However based on the Q3 transcript they will be including downstream as sales. Too much downstream and they miss earnings. Even though they should not be measured that way. SUNE is working on having no solar revenue, but will have some, they miss estimates each Qtr. Looking back at the trading action in11/20 Q3 when JKS beat big on earnings and light 40mw on revenue, it traded bad on earnings day, but recouped big on 11/21. Looking at options, there is a big open interest on the $20 Puts, 2000 contracts, trading last at .70 which is big bets on a miss. Someone early Fri on stocktwits said there is a 11% move in either direction based on options.
short term though it's bad news for FSLR and SPWR. When you retain MW you have costs and no sales. Were they already in the earnings estimates? Chances are, no, so it cause you to miss guidance and estimates.
maintain $34 Target Price
$34 value per share from $15 for Solar Development using a 17x 2016 pro-forma cash earnings multiple discounted back to today, $8 for SUNE's interest in TERP based on a 2016 dividend yield, $8/share for SUNE's IDRs in TERP, $1 for SUNE's interest in SEMI and less net debt
this is the most important announcement as it relates to SUNE. Recurrent undercut SUNE/TERP in the Austin TX deal back in May. We don't need these deals stinking up the place.